CH396894A - Verfahren zur Herstellung neuer Steroide - Google Patents
Verfahren zur Herstellung neuer SteroideInfo
- Publication number
- CH396894A CH396894A CH167165A CH167165A CH396894A CH 396894 A CH396894 A CH 396894A CH 167165 A CH167165 A CH 167165A CH 167165 A CH167165 A CH 167165A CH 396894 A CH396894 A CH 396894A
- Authority
- CH
- Switzerland
- Prior art keywords
- making new
- new steroids
- steroids
- making
- new
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J15/00—Stereochemically pure steroids containing carbon, hydrogen, halogen or oxygen having a partially or totally inverted skeleton, e.g. retrosteroids, L-isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NL226774 | 1958-04-12 | ||
NL232312 | 1958-10-15 | ||
NL236884 | 1959-03-07 | ||
NL237103 | 1959-03-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
CH396894A true CH396894A (de) | 1965-08-15 |
Family
ID=27483655
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH988565A CH452517A (de) | 1958-04-12 | 1959-04-09 | Verfahren zur Herstellung neuer Steroide |
CH7177159A CH398576A (de) | 1958-04-12 | 1959-04-09 | Verfahren zur Herstellung neuer Steroide |
CH167165A CH396894A (de) | 1958-04-12 | 1959-04-09 | Verfahren zur Herstellung neuer Steroide |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH988565A CH452517A (de) | 1958-04-12 | 1959-04-09 | Verfahren zur Herstellung neuer Steroide |
CH7177159A CH398576A (de) | 1958-04-12 | 1959-04-09 | Verfahren zur Herstellung neuer Steroide |
Country Status (2)
Country | Link |
---|---|
CH (3) | CH452517A (de) |
GB (4) | GB929275A (de) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2994092B1 (fr) * | 2012-08-03 | 2014-11-28 | Centre Nat Rech Scient | Nouveaux composes activateurs de l'activite enzymatique de sirt1 et compositions pharmaceutiques ou cosmetiques les comprenant |
-
1959
- 1959-04-09 CH CH988565A patent/CH452517A/de unknown
- 1959-04-09 GB GB4841359A patent/GB929275A/en not_active Expired
- 1959-04-09 CH CH7177159A patent/CH398576A/de unknown
- 1959-04-09 CH CH167165A patent/CH396894A/de unknown
- 1959-04-12 GB GB1202659A patent/GB929272A/en not_active Expired
- 1959-04-12 GB GB4814162A patent/GB929273A/en not_active Expired
- 1959-04-12 GB GB4814262A patent/GB929274A/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
GB929273A (en) | 1963-06-19 |
CH452517A (de) | 1968-03-15 |
GB929274A (en) | 1963-06-19 |
GB929275A (en) | 1963-06-19 |
GB929272A (en) | 1963-06-19 |
CH398576A (de) | 1966-03-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CH382153A (de) | Verfahren zur Herstellung neuer Steroidverbindungen | |
CH375005A (de) | Verfahren zur Herstellung neuer Steroidverbindungen | |
CH432506A (de) | Verfahren zur Herstellung neuer Steroide | |
CH374662A (de) | Verfahren zur Herstellung neuer 6-Fluor-Steroide | |
CH375352A (de) | Verfahren zur Herstellung neuer 6-Fluor-9a-halogensteroide | |
CH375353A (de) | Verfahren zur Herstellung neuer Steroidverbindungen | |
CH382742A (de) | Verfahren zur Herstellung neuer Steroidverbindungen | |
CH375003A (de) | Verfahren zur Herstellung neuer 6-Fluor-Steroide | |
CH396896A (de) | Verfahren zur Herstellung neuer Steroidverbindungen | |
CH376103A (de) | Verfahren zur Herstellung von Steroidverbindungen | |
CH397669A (de) | Verfahren zur Herstellung neuer Steroidverbindungen | |
CH387626A (de) | Verfahren zur Herstellung neuer Steroidverbindungen | |
CH381671A (de) | Verfahren zur Herstellung neuer Steroidverbindungen | |
CH452517A (de) | Verfahren zur Herstellung neuer Steroide | |
CH388307A (de) | Verfahren zur Herstellung neuer Steroide | |
CH378315A (de) | Verfahren zur Herstellung neuer Steroide | |
CH389597A (de) | Verfahren zur Herstellung neuer Steroidverbindungen | |
CH380117A (de) | Verfahren zur Herstellung neuer Steroidverbindungen | |
CH397668A (de) | Verfahren zur Herstellung neuer Steroidverbindungen | |
AT244000B (de) | Verfahren zur Herstellung neuer Steroidverbindungen | |
CH383959A (de) | Verfahren zur Herstellung neuer Steroidverbindungen | |
CH383958A (de) | Verfahren zur Herstellung neuer Steroidester | |
AT237201B (de) | Verfahren zur Herstellung neuer, anabol wirksamer Steroide | |
CH388308A (de) | Verfahren zur Herstellung neuer Steroidverbindungen | |
CH465600A (de) | Verfahren zur Herstellung neuer Steroide |